{
    "2021-05-31": [
        [
            {
                "time": "2021-06-01",
                "orginal_text": "凯莱英(002821.SZ)拟发行H股并在香港联交所主板上市",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "H股",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "凯莱英(002821.SZ)拟补选李家聪为独立董事",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "独立董事",
                        "李家聪"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "凯莱英(002821.SZ)拟聘请安永会计师事务所为H股IPO申报会计师",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "安永",
                        "H股IPO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "凯莱英：潘广成申请辞去公司独立董事等职务 董监高成员变化",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "潘广成",
                        "辞职"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "医疗健康产业2021年下半年投资策略：百花齐放 关注疫情后时代的医药强势复苏",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "投资策略",
                        "疫情后",
                        "复苏"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "券商5月金股组合\"战绩\"：开源证券14.13%夺冠 中泰最差",
                "features": {
                    "keywords": [
                        "券商",
                        "金股组合",
                        "开源证券",
                        "中泰"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "粤开医药行业周报|12省骨科创伤耗材带量采购启动，国药集团新冠疫苗Ⅲ期临床数据出炉",
                "features": {
                    "keywords": [
                        "医药",
                        "带量采购",
                        "新冠疫苗",
                        "国药集团"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "医药周报：骨修复材料市场增速近20% 人工材料为骨移植的新选择",
                "features": {
                    "keywords": [
                        "医药",
                        "骨修复材料",
                        "人工材料"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "医药生物行业跨市场周报：汇率影响有限 CXO行业景气度仍处于上行阶段",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "景气度",
                        "汇率"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "八大券商主题策略：医药板块兼具科技加消费属性！未来3-5年是国产疫苗的黄金时代",
                "features": {
                    "keywords": [
                        "医药",
                        "科技",
                        "消费",
                        "国产疫苗",
                        "黄金时代"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "医药行业周报：医药成“战略”投资 个股重视变化",
                "features": {
                    "keywords": [
                        "医药",
                        "战略投资",
                        "个股变化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-01",
                "orginal_text": "中信证券：医药投资进入了百花齐放的新时期",
                "features": {
                    "keywords": [
                        "中信证券",
                        "医药投资",
                        "百花齐放"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}